A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

The new trial focused on patients with advanced, stage 3 or 4 clear cell renal [kidney] cell carcinoma (ccRCC).

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.